Cannabis Science and Policy Summit 2016

The bulk of state-legal cannabis sales runs through systems of medical availability. The product mix in the medical sector has been changing rapidly. Alongside the legal effort and the production and distribution activities that constitute the medical-marijuana system, there now exists a growing effort at clinical research, despite hostile federal regulation.

How have the available products evolved over time?

How have their market shares changed over time?

How do, and can, state governments regulate the development of cannabis-derived medical products?

Is there a path to federal approval of cannabis medications?

Moderator:

Brad Rowe, President & Managing Director, BOTEC Analysis

Speakers:

Rose Habib, Director of Processing, The Werc Shop

Sue Sisley, Chief Medical Director, NY Bloomfield Industries

Nicholas Vita, Vice Chairman & CEO, Columbia Care

Alice Mead, Vice President – U.S. Professional Relations, GW Pharmaceuticals